enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
7.51
+0.01 (0.13%)
Nov 21, 2024, 1:12 PM EST - Market open
enGene Holdings Income Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Jul '24 Jul 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 |
Selling, General & Admin | 22.57 | 9.6 | 3.96 | 3.41 | 3.24 |
Research & Development | 32.71 | 16.46 | 15.47 | 12.46 | 10.61 |
Operating Expenses | 55.28 | 26.06 | 19.43 | 15.87 | 13.85 |
Operating Income | -55.28 | -26.06 | -19.43 | -15.87 | -13.85 |
Interest Expense | -3.2 | -4.95 | -1.42 | -5.02 | -3.7 |
Interest & Investment Income | 7.8 | 1.12 | 0.13 | 0.03 | 0.06 |
Currency Exchange Gain (Loss) | 0.41 | -0.1 | -0.7 | -0.1 | -0.1 |
Other Non Operating Income (Expenses) | -15.35 | -10.6 | -3.02 | -4.2 | 0.97 |
EBT Excluding Unusual Items | -65.63 | -40.6 | -24.44 | -25.17 | -16.63 |
Other Unusual Items | -56.73 | -59.3 | - | 1.73 | 1.56 |
Pretax Income | -122.36 | -99.9 | -24.44 | -23.44 | -15.07 |
Income Tax Expense | -0.02 | 0.02 | 0.02 | - | - |
Net Income | -122.34 | -99.92 | -24.46 | -23.44 | -15.07 |
Preferred Dividends & Other Adjustments | 1.1 | 4.82 | 4.56 | -1.19 | 1.58 |
Net Income to Common | -123.44 | -104.74 | -29.02 | -22.25 | -16.65 |
Shares Outstanding (Basic) | 27 | 1 | 1 | 4 | 3 |
Shares Outstanding (Diluted) | 27 | 1 | 1 | 4 | 3 |
Shares Change (YoY) | 590.98% | 5.72% | -81.61% | 28.93% | - |
EPS (Basic) | -4.60 | -151.22 | -44.30 | -6.25 | -6.02 |
EPS (Diluted) | -4.60 | -151.22 | -44.30 | -6.25 | -6.02 |
Free Cash Flow | -36.31 | -25.06 | -17.75 | -16.23 | -13.25 |
Free Cash Flow Per Share | -1.35 | -36.18 | -27.09 | -4.56 | -4.80 |
EBITDA | -55 | -25.89 | -19.19 | -15.6 | -13.59 |
D&A For EBITDA | 0.29 | 0.18 | 0.24 | 0.27 | 0.26 |
EBIT | -55.28 | -26.06 | -19.43 | -15.87 | -13.85 |
Source: S&P Capital IQ. Standard template.
Financial Sources.